Elanco Launches Varenzin-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease - Seite 3

Elura Indication:

Elura is indicated for management of weight loss in cats with chronic kidney disease.

Elura Important Safety Information:

For oral use in cats only. Do not use in cats that have a hypersensitivity to capromorelin or in cats with hypersomatotropism (acromegaly). Elura may increase serum glucose for several hours after dosing; use in cats with current or historical diabetes mellitus has not been evaluated and may not be appropriate. Use with caution in cats that may have cardiac disease, severe dehydration or hepatic dysfunction. Elura has not been evaluated in cats younger than 5 months of age or in breeding, pregnant or lactating cats. The most common adverse reactions included vomiting, hypersalivation, inappetence, behavior change and lethargy. Click here to see Elura product label for full prescribing information.

ABOUT ELANCO

Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching Life and our approach to sustainability, Elanco Healthy Purpose– all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com.

ⁱ FDA Conditionally Approves First Drug for Anemia in Cats with Chronic Kidney Disease | FDA

ⁱⁱ Chalhoub S, et al. Anemia of renal disease: what it is, what to do and what's new. J Feline Med Surg. 2011;13(9):629-40.

ⁱⁱⁱ Boyd LM, et al. Survival in cats with naturally occurring chronic kidney disease (2000-2002). J Vet Intern Med. 2008;22:1111-17

Elura, Varenzin, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. @2023 Elanco or its affiliates.

PM-US-23-0888

View source version on businesswire.com: https://www.businesswire.com/news/home/20230907527480/en/

The Elanco Animal Health Stock at the time of publication of the news with a fall of -1,79 % to 10,96EUR on Lang & Schwarz stock exchange (07. September 2023, 22:18 Uhr).